These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16677000)

  • 1. Proteomimetic libraries: design, synthesis, and evaluation of p53-MDM2 interaction inhibitors.
    Lu F; Chi SW; Kim DH; Han KH; Kuntz ID; Guy RK
    J Comb Chem; 2006; 8(3):315-25. PubMed ID: 16677000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction.
    Surmiak E; Neochoritis CG; Musielak B; Twarda-Clapa A; Kurpiewska K; Dubin G; Camacho C; Holak TA; Dömling A
    Eur J Med Chem; 2017 Jan; 126():384-407. PubMed ID: 27907876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment.
    Zhao Y; Aguilar A; Bernard D; Wang S
    J Med Chem; 2015 Feb; 58(3):1038-52. PubMed ID: 25396320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational studies and peptidomimetic design for the human p53-MDM2 complex.
    Zhong H; Carlson HA
    Proteins; 2005 Jan; 58(1):222-34. PubMed ID: 15505803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence polarization assay and inhibitor design for MDM2/p53 interaction.
    Zhang R; Mayhood T; Lipari P; Wang Y; Durkin J; Syto R; Gesell J; McNemar C; Windsor W
    Anal Biochem; 2004 Aug; 331(1):138-46. PubMed ID: 15246006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting protein-protein interactions: lessons from p53/MDM2.
    Murray JK; Gellman SH
    Biopolymers; 2007; 88(5):657-86. PubMed ID: 17427181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction.
    Pettersson M; Quant M; Min J; Iconaru L; Kriwacki RW; Waddell MB; Guy RK; Luthman K; Grøtli M
    PLoS One; 2015; 10(10):e0137867. PubMed ID: 26427060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy.
    Lu Y; Nikolovska-Coleska Z; Fang X; Gao W; Shangary S; Qiu S; Qin D; Wang S
    J Med Chem; 2006 Jun; 49(13):3759-62. PubMed ID: 16789731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule inhibitors of the p53-MDM2 interaction.
    Vu BT; Vassilev L
    Curr Top Microbiol Immunol; 2011; 348():151-72. PubMed ID: 21046355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity-based screening of MDM2/MDMX-p53 interaction inhibitors by chemical array: identification of novel peptidic inhibitors.
    Noguchi T; Oishi S; Honda K; Kondoh Y; Saito T; Kubo T; Kaneda M; Ohno H; Osada H; Fujii N
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3802-5. PubMed ID: 23726030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction.
    Zhuang C; Miao Z; Zhu L; Zhang Y; Guo Z; Yao J; Dong G; Wang S; Liu Y; Chen H; Sheng C; Zhang W
    Eur J Med Chem; 2011 Nov; 46(11):5654-61. PubMed ID: 21996465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel dihydroimidazothiazole derivatives as p53-MDM2 protein-protein interaction inhibitors: synthesis, biological evaluation and structure-activity relationships.
    Miyazaki M; Kawato H; Naito H; Ikeda M; Miyazaki M; Kitagawa M; Seki T; Fukutake S; Aonuma M; Soga T
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6338-42. PubMed ID: 22995624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel dual inhibitors against Mdm2 and Mdmx proteins by in silico approaches and binding assay.
    Golestanian S; Sharifi A; Popowicz GM; Azizian H; Foroumadi A; Szwagierczak A; Holak TA; Amanlou M
    Life Sci; 2016 Jan; 145():240-6. PubMed ID: 26746660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction.
    Furet P; Chène P; De Pover A; Valat TS; Lisztwan JH; Kallen J; Masuya K
    Bioorg Med Chem Lett; 2012 May; 22(10):3498-502. PubMed ID: 22507962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligobenzamide proteomimetic inhibitors of the p53-hDM2 protein-protein interaction.
    Plante JP; Burnley T; Malkova B; Webb ME; Warriner SL; Edwards TA; Wilson AJ
    Chem Commun (Camb); 2009 Sep; (34):5091-3. PubMed ID: 20448956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and in vitro and in vivo antitumour activity of 3-benzylideneindolin-2-one derivatives, a novel class of small-molecule inhibitors of the MDM2-p53 interaction.
    Zheng GH; Shen JJ; Zhan YC; Yi H; Xue ST; Wang Z; Ji XY; Li ZR
    Eur J Med Chem; 2014 Jun; 81():277-88. PubMed ID: 24852275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR structure of a complex between MDM2 and a small molecule inhibitor.
    Fry DC; Emerson SD; Palme S; Vu BT; Liu CM; Podlaski F
    J Biomol NMR; 2004 Oct; 30(2):163-73. PubMed ID: 15557803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A re-examination of the MDM2/p53 interaction leads to revised design criteria for novel inhibitors.
    Vasilevich NI; Afanasyev II; Kovalskiy DA; Genis DV; Kochubey VS
    Chem Biol Drug Des; 2014 Nov; 84(5):585-92. PubMed ID: 24797588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors.
    Hu C; Li X; Wang W; Zhang L; Tao L; Dong X; Sheng R; Yang B; Hu Y
    Bioorg Med Chem; 2011 Sep; 19(18):5454-61. PubMed ID: 21855354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational changes of the p53-binding cleft of MDM2 revealed by molecular dynamics simulations.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Biopolymers; 2006 Nov; 83(4):365-73. PubMed ID: 16817233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.